041830.KQ InBody Co.,Ltd
KOEHealthcareAs of 2026-08-09 03:23
Why 041830.KQ matters now
InBody Co.,Ltd (041830.KQ) is a Korea stock in Healthcare. The latest InvestLog snapshot shows ₩70,800.00 with +1.14% on the session and ₩954.45B in market capitalization.
Valuation context is available even where detailed statement rows are sparse: InvestLog currently shows P/E 22.79, gross margin 75.5%, and operating margin 17.2%.
Valuation
P/E (TTM)
22.79
PEG
—
P/B
2.90
P/S
3.83
EV/EBITDA
10.08
DCF Value
—
FCF Yield
3.3%
Div Yield
0.8%
Margins & Returns
Gross Margin
75.5%
Operating Margin
17.2%
Net Margin
16.2%
ROE
13.4%
ROA
10.5%
ROIC
10.1%
Listing Info
Market
Korea
Exchange
KOE
Currency
KRW
Sector
Healthcare
Industry
Medical - Specialties
Country
KR
InBody Co.,Ltd is a global provider of advanced body composition analysis solutions. The company offers an extensive product line, including body composition analyzers, blood pressure monitors, stadiometers, and body water analyzers, along with specialized devices like the InBody Dial and various bands. These technologies are widely employed across diverse applications, such as medical specialties like nephrology, liver disease, and diabetes, as well as in nutrition and rehabilitation programs. Originally established in 1996 and headquartered in Seoul, South Korea, the company was formerly known as Biospace Co., Ltd.